Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	APO- Levodopa/Carbidopa 100/25
Active Ingredients:	Carbidopa monohydrate 27mg equivalent to carbidopa 25mg Levodopa 100mg
Dosage Form:	Tablet
New Zealand Sponsor:	Arrotex Pharmaceuticals (NZ) Limited
Manufacturers:	Evertogen Life Sciences Limited, Polepally, India Titan Laboratories Pvt Limited, Jite, India

*Product:*	APO- Levodopa/Carbidopa 250/25
Active Ingredients:	Carbidopa monohydrate 27mg equivalent to carbidopa 25mg Levodopa 250mg
Dosage Form:	Tablet
New Zealand Sponsor:	Arrotex Pharmaceuticals (NZ) Limited
Manufacturers:	Evertogen Life Sciences Limited, Polepally, India Titan Laboratories Pvt Limited, Jite, India

*Product:*	Levodopa/Carbidopa 100/25
Active Ingredients:	Carbidopa monohydrate 27mg equivalent to carbidopa 25mg Levodopa 100mg
Dosage Form:	Tablet
New Zealand Sponsor:	Arrotex Pharmaceuticals (NZ) Limited
Manufacturers:	Evertogen Life Sciences Limited, Polepally, India Titan Laboratories Pvt Limited, Jite, India

*Product:*	Levodopa/Carbidopa 250/25
Active Ingredients:	Carbidopa monohydrate 27mg equivalent to carbidopa 25mg Levodopa 250mg
Dosage Form:	Tablet
New Zealand Sponsor:	Arrotex Pharmaceuticals (NZ) Limited
Manufacturers:	Evertogen Life Sciences Limited, Polepally, India Titan Laboratories Pvt Limited, Jite, India

*Product:*	Medco Paracetamol
Active Ingredient:	Paracetamol 500mg
Dosage Form:	Tablet
New Zealand Sponsor:	PSM Healthcare Limited trading as API Consumer Brands
Manufacturer:	PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand

Dated this 17th day of September 2021.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule